Association between excessive fetal growth and maternal cancer in Shanghai, China: a large, population-based cohort study

[1]  E. M. van der Beek,et al.  Macrosomia and large for gestational age in Asia: One size does not fit all , 2021, The journal of obstetrics and gynaecology research.

[2]  A. Swerdlow,et al.  Maternal breast cancer risk in relation to birthweight and gestation of her offspring , 2018, Breast Cancer Research.

[3]  N. Stentz,et al.  Big data approach to evaluation of birth defects and assisted reproductive technology: the Chinese linkage cohort. , 2018, Fertility and Sterility.

[4]  Huiting Yu,et al.  Association of birth defects with the mode of assisted reproductive technology in a Chinese data-linkage cohort. , 2018, Fertility and sterility.

[5]  M. Gissler,et al.  The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence , 2018, Journal of internal medicine.

[6]  A. Hansell,et al.  Birth weight trends in England and Wales (1986–2012): babies are getting heavier , 2017, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[7]  T. Bungum,et al.  Gestational Age and the Risk of Maternal Breast Cancer: A Population‐Based Case–Control Study , 2016, The breast journal.

[8]  J. Sundquist,et al.  Fetal growth and subsequent maternal risk of thyroid cancer , 2016, International journal of cancer.

[9]  J. Sundquist,et al.  Fetal Growth and Subsequent Maternal Risk of Colorectal Cancer , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[10]  H. Adami,et al.  Maternal and cord blood hormones in relation to birth size , 2014, European Journal of Epidemiology.

[11]  P. Albert,et al.  Customized large-for-gestational-age birthweight at term and the association with adverse perinatal outcomes. , 2014, American journal of obstetrics and gynecology.

[12]  J. Sundquist,et al.  Perinatal and family risk factors for Hodgkin lymphoma in childhood through young adulthood. , 2012, American journal of epidemiology.

[13]  A. Belfiore,et al.  New advances on the functional cross-talk between insulin-like growth factor-I and estrogen signaling in cancer. , 2012, Cellular signalling.

[14]  J. Sundquist,et al.  Perinatal and family risk factors for non-Hodgkin lymphoma in early life: a Swedish national cohort study. , 2012, Journal of the National Cancer Institute.

[15]  Jun Zhang,et al.  Secular trends of macrosomia in southeast China, 1994-2005 , 2011, BMC public health.

[16]  Marian Kelley,et al.  One size does not fit all. , 2011, Bioanalysis.

[17]  N. Paneth,et al.  American Journal of Epidemiology Original Contribution a Population-based Case-control Study of Fetal Growth, Gestational Age, and Maternal Breast Cancer , 2022 .

[18]  Andrew W Roddam,et al.  Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies , 2010, The Lancet. Oncology.

[19]  W. Lu,et al.  Time trends and characteristics of childhood cancer among children age 0–14 in Shanghai , 2009, Pediatric blood & cancer.

[20]  M. Pollak.  Insulin, insulin-like growth factors and neoplasia. , 2008, Best practice & research. Clinical endocrinology & metabolism.

[21]  H. Adami,et al.  Gestational Age and Fetal Growth in Relation to Maternal Ovarian Cancer Risk in a Swedish Cohort , 2007, Cancer Epidemiology Biomarkers & Prevention.

[22]  M. Melbye,et al.  Birth weight and risk of cancer , 2007, Cancer.

[23]  R. Luoto,et al.  Preventing excessive weight gain during pregnancy – a controlled trial in primary health care , 2007, European Journal of Clinical Nutrition.

[24]  C. Nagata,et al.  Estrogen and α-Fetoprotein Levels in Maternal and Umbilical Cord Blood Samples in Relation to Birth Weight , 2006, Cancer Epidemiology Biomarkers & Prevention.

[25]  V. McCormack,et al.  Birth characteristics and adult cancer incidence: Swedish cohort of over 11,000 men and women , 2005, International journal of cancer.

[26]  S. Hankinson,et al.  A Prospective Study of C-Peptide, Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-1, and the Risk of Colorectal Cancer in Women , 2005, Cancer Epidemiology Biomarkers & Prevention.

[27]  S. Hankinson,et al.  Insulin-like growth factors and neoplasia , 2004, Nature Reviews Cancer.

[28]  J. Clapp,et al.  Maternal insulin-like growth factor-I levels (IGF-I) reflect placental mass and neonatal fat mass. , 2004, American journal of obstetrics and gynecology.

[29]  R. Hoover,et al.  Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors (United States) , 2003, Cancer Causes & Control.

[30]  David A Savitz,et al.  Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy. , 2003, American journal of epidemiology.

[31]  J. Williams,et al.  IN A POPULATION-BASED CASE-CONTROL STUDY , 2001 .

[32]  S. Cnattingius,et al.  Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. , 2000, Epidemiology.

[33]  P. Trayhurn,et al.  Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy , 1997, Clinical endocrinology.

[34]  H. Hoffman,et al.  Maternal serum concentrations of human placental lactogen, estradiol and pregnancy specific beta 1-glycoprotein and fetal growth retardation. , 1997, Acta obstetricia et gynecologica Scandinavica. Supplement.

[35]  H. Hoffman,et al.  Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol. , 1997, Acta obstetricia et gynecologica Scandinavica. Supplement.

[36]  R. Snow,et al.  Review of the Evidence. , 1964, Science.